ATE529454T1 - Biokompatibles, nicht biologisch abbaubares, nichttoxisches polymer, das zur verwendung für pharmazeutische nanopartikelzusammensetzungen geeignet ist - Google Patents

Biokompatibles, nicht biologisch abbaubares, nichttoxisches polymer, das zur verwendung für pharmazeutische nanopartikelzusammensetzungen geeignet ist

Info

Publication number
ATE529454T1
ATE529454T1 AT06832316T AT06832316T ATE529454T1 AT E529454 T1 ATE529454 T1 AT E529454T1 AT 06832316 T AT06832316 T AT 06832316T AT 06832316 T AT06832316 T AT 06832316T AT E529454 T1 ATE529454 T1 AT E529454T1
Authority
AT
Austria
Prior art keywords
biocompatible
biodegradable
nanoparticle compositions
polymer suitable
toxic polymer
Prior art date
Application number
AT06832316T
Other languages
English (en)
Inventor
Anand Burman
Rama Mukherjee
Dhiraj Khattar
Sanjoy Mullick
Manu Jaggi
Manoj Singh
Mukesh Kumar
Deepak Prusthy
Pawan Gupta
Rajendran Praveen
Shobhit Singh
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Application granted granted Critical
Publication of ATE529454T1 publication Critical patent/ATE529454T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/56—Acrylamide; Methacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/04—Anhydrides, e.g. cyclic anhydrides
    • C08F222/06—Maleic anhydride
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10—Esters
    • C08F222/12—Esters of phenols or saturated alcohols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F226/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C08F226/10—N-Vinyl-pyrrolidone
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/36—Amides or imides
    • C08F222/38—Amides
    • C08F222/385—Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
AT06832316T 2005-12-28 2006-12-26 Biokompatibles, nicht biologisch abbaubares, nichttoxisches polymer, das zur verwendung für pharmazeutische nanopartikelzusammensetzungen geeignet ist ATE529454T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1190KO2005 2005-12-28
PCT/IN2006/000504 WO2007074476A1 (en) 2005-12-28 2006-12-26 A biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE529454T1 true ATE529454T1 (de) 2011-11-15

Family

ID=37845115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06832316T ATE529454T1 (de) 2005-12-28 2006-12-26 Biokompatibles, nicht biologisch abbaubares, nichttoxisches polymer, das zur verwendung für pharmazeutische nanopartikelzusammensetzungen geeignet ist

Country Status (19)

Country Link
US (2) US8338562B2 (de)
EP (2) EP1971622B1 (de)
JP (1) JP2009522251A (de)
KR (2) KR20080091158A (de)
CN (1) CN101336256B (de)
AR (1) AR058866A1 (de)
AT (1) ATE529454T1 (de)
AU (1) AU2006329554C1 (de)
BR (1) BRPI0620745A2 (de)
CA (1) CA2635469A1 (de)
EA (1) EA017682B1 (de)
ES (2) ES2375740T3 (de)
HK (1) HK1123814A1 (de)
IL (1) IL192423A0 (de)
MX (1) MX2008008423A (de)
MY (1) MY148575A (de)
NZ (1) NZ569372A (de)
WO (1) WO2007074476A1 (de)
ZA (1) ZA200806548B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2375740T3 (es) 2005-12-28 2012-03-05 Fresenius Kabi Oncology Limited Pol�?mero no tóxico, no biodegradable, biocompatible, útil para composiciones farmacéuticas con nanopart�?culas.
JP5420946B2 (ja) 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
CN101845120B (zh) * 2010-03-25 2011-11-16 淮阴师范学院 一种温敏和生物可降解性原位凝胶的合成方法
US8921429B2 (en) 2010-11-23 2014-12-30 Howard University Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
US8772355B2 (en) * 2010-11-23 2014-07-08 Howard University Stealth polymeric particles for delivery of bioactive or diagnostic agents
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2013184978A2 (en) * 2012-06-07 2013-12-12 David Moscatello Compositions and methods for collecting, washing, cryopreserving, recovering and return of lipoaspirates to physician for autologous adipose transfer procedures
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
WO2015187947A1 (en) * 2014-06-04 2015-12-10 Izard Ryan Methods and compositions for orally dosing postnatal swine
CN104119474B (zh) * 2014-06-26 2016-06-15 中国人民解放军第三○九医院 一种表面功能化的微纳米聚合物空心粒子及其制备方法
CN104119475B (zh) * 2014-06-26 2016-06-15 中国人民解放军第三○九医院 一种表面功能化的微纳米聚合物凝胶粒子及其制备方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10176182B2 (en) 2015-08-31 2019-01-08 International Business Machines Corporation File deletion in storage devices based on the deletion priority rules
EP3153227A1 (de) * 2015-10-07 2017-04-12 Evonik Degussa GmbH Verfahren zur herstellung von polyalkenameren für verpackungsanwendungen
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US636519A (en) 1899-04-14 1899-11-07 Elisha Gray Transmission of sound.
JP2517760B2 (ja) 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
KR940003548U (ko) 1992-08-14 1994-02-21 김형술 세탁물 건조기
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5362478A (en) 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5916596A (en) 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US6096331A (en) 1993-02-22 2000-08-01 Vivorx Pharmaceuticals, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US6537579B1 (en) 1993-02-22 2003-03-25 American Bioscience, Inc. Compositions and methods for administration of pharmacologically active compounds
US5874111A (en) 1997-01-07 1999-02-23 Maitra; Amarnath Process for the preparation of highly monodispersed polymeric hydrophilic nanoparticles
IT1293823B1 (it) * 1997-08-05 1999-03-10 Stefano Gasparini Materiale plastico non tossico avente proprieta' di adsorbenza e assorbenza e relativo procedimento di fabbricazione
US6403816B1 (en) 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
US5830964A (en) * 1997-12-18 1998-11-03 Isp Investments Inc. Vinyl pyrrolidone polymers substantially free of vinyl lactam monomers
IN191203B (de) * 1999-02-17 2003-10-04 Amarnath Prof Maitra
US6365191B1 (en) 1999-02-17 2002-04-02 Dabur Research Foundation Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
US6617420B2 (en) * 2000-08-11 2003-09-09 Nippon Shokubai Co., Ltd. Process for reducing monomer content in N-vinyl compound polymers
US8545830B2 (en) 2003-03-24 2013-10-01 University Of Tennessee Research Foundation Multi-functional polymeric materials and their uses
ES2375740T3 (es) 2005-12-28 2012-03-05 Fresenius Kabi Oncology Limited Pol�?mero no tóxico, no biodegradable, biocompatible, útil para composiciones farmacéuticas con nanopart�?culas.
JP2010505877A (ja) * 2006-10-05 2010-02-25 ザ・ジョンズ・ホプキンス・ユニバーシティー スマートな高分子ナノ粒子を用いた低水溶性薬物用の水分散性経口、非経口および局所的製剤

Also Published As

Publication number Publication date
ES2375740T3 (es) 2012-03-05
CN101336256A (zh) 2008-12-31
AU2006329554B2 (en) 2013-01-10
AU2006329554A1 (en) 2007-07-05
MY148575A (en) 2013-04-30
KR20080091158A (ko) 2008-10-09
US8927023B2 (en) 2015-01-06
JP2009522251A (ja) 2009-06-11
BRPI0620745A2 (pt) 2013-02-19
NZ569372A (en) 2011-10-28
EA017682B1 (ru) 2013-02-28
CN101336256B (zh) 2012-03-28
US20090318661A1 (en) 2009-12-24
MX2008008423A (es) 2008-09-23
CA2635469A1 (en) 2007-07-05
KR20130116954A (ko) 2013-10-24
HK1123814A1 (en) 2009-06-26
WO2007074476A1 (en) 2007-07-05
EP1971622A1 (de) 2008-09-24
EA200801563A1 (ru) 2009-06-30
US20130274211A1 (en) 2013-10-17
EP1971622B1 (de) 2011-10-19
EP2172497A1 (de) 2010-04-07
EP2172497B1 (de) 2013-05-22
AR058866A1 (es) 2008-02-27
US8338562B2 (en) 2012-12-25
AU2006329554C1 (en) 2013-06-20
ZA200806548B (en) 2010-02-24
ES2425075T3 (es) 2013-10-11
IL192423A0 (en) 2008-12-29

Similar Documents

Publication Publication Date Title
ATE529454T1 (de) Biokompatibles, nicht biologisch abbaubares, nichttoxisches polymer, das zur verwendung für pharmazeutische nanopartikelzusammensetzungen geeignet ist
BRPI1012051A2 (pt) "composição para o cuidado oral, filme de matriz polimétrica, e métodos para preparar o filme, e para tratar uma doença ou condição da cavidade oral"
BRPI0913492A2 (pt) "unidade de bloqueio tendo mecanismo de fechamento com linguetas multiplas"
EP2074383A4 (de) Computerisiertes c-arm-tomographiesystem
EP1933881A4 (de) Feste polymer-abgabezusammensetzungen und anwendungsverfahren dafür
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0717697A2 (pt) composto, composição farmaceutica, uso do composto, método para tratar um paciente sofrendo de uma condição patológica ou uma doença e combinação de produtos
BRPI0722082A2 (pt) Ligantes para imagiologia da inervação cardíaca
BRPI0717498A2 (pt) Composições, métodos de preparo de uma solução para preparo cirúrgico utilizada para desinfetar uma região pré-operatória, métodos de desinfecção, e dispositivo médico.
BRPI0716559A2 (pt) material ou vestimenta cirérgica, estrutura de suporte mÉdica, e, mÉtodo para produzir um material ou uma vestimenta cirérgica ou uma estrutura de suporte mÉdica
DE112008002791A5 (de) Verbesserte arzneimittelbeschichtete Medizinprodukte, deren Herstellung und Verwendung
ZA200806758B (en) Sterilized nanoparticulate glucocorticosteroid formulations
BRPI0716439A2 (pt) formulaÇÕes de flibanserina e mÉtodo para fabricaÇço das mesmas.
BRPI0815321A2 (pt) "composição, plataforma, kit uso de uma composição, método de diagnóstico, método de manufatura da composição, método de manufatura da plataforma, método de manufatura do kit"
EP1940877A4 (de) Modifizierte biologisch abbaubare polymere, herstellung und verwendung davon zur herstellung von biomaterialien und verbänden
BRPI0913293A2 (pt) método para inibir a formação de uma biopelícula, composição farmacêutica tópica, rinsagem cirúrgica, bandagem, composição de limpeza, e, rinsagem dental.
DE602006020674D1 (de) Polymerzusammensetzung
FI20070768L (fi) Röntgentietokonetomografialaitteisto
IL212568A (en) Annotated 4,1-Diazepan, Pharmaceutical Preparations Containing Them and Their Uses in the Preparation of Medicines for the Treatment of Diseases or Disorders of Mammals
DE602006013999D1 (de) Flammwidrige polymerzusammensetzungen
EP2026756A4 (de) Resorbierbare polymerzusammensetzungen zur verwendung in der medizin, zahnmedizin und chirurgie
IT1391734B1 (it) Nuovi biomateriali, loro preparazione per elettrospinning e loro uso in campo biomedico e chirurgico.
BRPI0816175A2 (pt) Composições adequadas para tratamento de doença, distúrbio ou condição da espinha.
ATE460401T1 (de) 1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
BRPI0816392A2 (pt) composição para o cuidado doméstico e de tecidos, e, método para a coloração da mesma.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties